Skip to content

Drug interactions

Amobarbital + Pazopanib

Severity: Major

Amobarbital and Pazopanib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Barbiturates induce CYP3A4, the main metabolic pathway of pazopanib, and may lower its exposure and antitumor efficacy. Pazopanib labeling advises avoiding strong CYP3A4 inducers.

What this interaction means in plain words

Amobarbital and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Amobarbital belongs to Central Nervous System; Pazopanib belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP3A4 induction by amobarbital increases pazopanib clearance.

What to do

Avoid combination where possible and use a non-inducing alternative. If unavoidable, monitor tumor response and toxicity closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amobarbital and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Amobarbital with Pazopanib?

MediHelp rates the interaction as major. Amobarbital and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Barbiturates induce CYP3A4, the main metabolic pathway of pazopanib, and may lower its exposure and antitumor efficacy. Pazopanib labeling advises avoiding strong CYP3A4 inducers.

How serious is the interaction between Amobarbital and Pazopanib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combination where possible and use a non-inducing alternative. If unavoidable, monitor tumor response and toxicity closely.

What other medicines interact with Amobarbital?

MediHelp also lists interactions of Amobarbital with, for example, Calcium / magnesium / potassium / sodium oxybates, Doravirine, Elbasvir / grazoprevir. The full list is on the Amobarbital page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in